Trial Profile
Clinical Trials Insight: 700028159
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2007
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Bayer HealthCare Pharmaceuticals Inc.; Onyx Pharmaceuticals
- 05 Nov 2007 New trial record.